Antibacterial combination of oleoresin from Copaifera multijuga Hayne and biogenic silver nanoparticles towards Streptococcus agalactiae.

CONCLUSION: These results indicate the potential of copaiba oil, alone or in combination with AgNPbio, for the development of new alternative strategies for controlling GBS infections.
PMID: 27978809 [PubMed - as supplied by publisher]

Source: Current Pharmaceutical Biotechnology - December 12, 2016 Category: Biotechnology Authors: Otaguiri ES, Morguette A, Biasi-Garbin RP, Morey AT, Lancheros C, Kian D, Oliveira AG, Kerbauy G, Perugini M, Durán N, Nakamura CV, Veiga Junior VF, Nakazato G, Pinge-Filho P, Yamauchi LM, Yamada-Ogatta SF Tags: Curr Pharm Biotechnol Source Type: research